TNFR1 signaling converging on FGF14 controls neuronal hyperactivity and sickness behavior in experimental cerebral

Nolan M Dvorak1, Nadia D Domingo2,3, Cynthia M Tapia1

  • 1Department of Pharmacology & Toxicology, University of Texas Medical Branch, Galveston, TX, 77555, USA.

PubMed
Abstract

Insights

Excess tumor necrosis factor (TNF) drives experimental cerebral malaria (eCM) neuroinflammation. This study reveals fibroblast growth factor 14 (FGF14) as a key mediator of neuronal hyperexcitability and sickness behavior in eCM, suggesting it as a therapeutic target.

Area of Science:

  • Neuroscience
  • Immunology
  • Pathology

Background:

  • Excessive tumor necrosis factor (TNF) contributes to hyperinflammatory experimental cerebral malaria (eCM) pathogenesis.
  • The precise role of TNF in neuronal dysfunction during eCM remains unclear.
  • This study investigates TNF-driven neuronal excitability changes and signaling pathways in eCM.

Purpose of the Study:

  • To elucidate the electrophysiological consequences of eCM on neuronal excitability.
  • To identify cell signaling mechanisms underlying TNF-induced neuronal dysfunction in eCM.
  • To investigate the therapeutic potential of targeting identified pathways in eCM.

Main Methods:

  • Split-luciferase complementation assay (LCA) to study signaling downstream of tumor necrosis factor receptor 1 (TNFR1).
  • Whole-cell patch-clamp electrophysiology in brain slices from eCM mice to assess CA1 pyramidal neuron excitability.
  • In vivo genetic silencing to evaluate the role of signaling molecules in eCM-induced behavioral changes.

Main Results:

  • TNF stimulation via TNFR1 increases the complex assembly of fibroblast growth factor 14 (FGF14) and voltage-gated sodium channel 1.6 (Nav1.6) through Janus Kinase 2 (JAK2).
  • Plasmodium chabaudi infection augments Nav1.6 channel conductance in CA1 pyramidal neurons via the TNFR1-JAK2-FGF14-Nav1.6 pathway, leading to hyperexcitability.
  • Anti-TNF antibody and FGF14 genetic silencing in CA1 mitigated neuronal hyperexcitability and reduced sickness behavior in eCM.

Conclusions:

  • The TNFR1-JAK2-FGF14-Nav1.6 signaling network mediates TNF-induced neuronal hyperexcitability in eCM.
  • FGF14 is a critical component of the neuroinflammatory cascade in eCM.
  • FGF14 inhibition presents a potential therapeutic strategy for managing neuroinflammation and associated symptoms in eCM.